Contribute Try STAT+ Today

More than 50 Democratic lawmakers have told President Trump that he can take one step himself to lower drug prices:  Instruct the National Institutes of Health to override patents for medicines that were discovered with federal funds, but carry price tags that are out of reach for many Americans.

In a letter sent on Tuesday, they argued the NIH should be encouraged to pursue so-called march-in rights. Under a 1980 federal law, this allows an agency that funds private research to require a drug maker to license its patent to another party in order to “alleviate health and safety needs which are not being reasonably satisfied” or when the benefits of a drug are not available on “reasonable terms.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Pharma will buy the legislatures in hurry and will make sure such an override is never signed. Pharma want to have profits and tax benefits and who cares about patients. They will die sooner or later.

Comments are closed.